A REVIEW OF LIBMELDY

The tablet formulation of zanubrutinib (Brukinsa; BeOne) has become accepted for all 5 indications across numerous hematological cancers.To generate Libmeldy, the CD34+ cells (cells that could make white blood cells) are extracted through the blood or bone marrow. A gene making it possible for them to help make ARSA is inserted in the CD34+ cells u